The Post-Translational Modification-Mediated Regulation of Oxidative Stress in Bone Metabolism
- 1Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China
- 2College of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China
- 3Fujian Key Laboratory of Integrative Medicine on Geriatrics, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China
Abstract
Bone remodeling depends on the dynamic equilibrium between osteogenic and osteoclastic processes, and its imbalance is considered one of the important foundations for the occurrence of bone metabolic diseases such as osteoporosis, osteoarthritis, and inflammation-related bone destruction, and may contribute to promoting their development. Oxidative stress can disrupt intracellular redox homeostasis through excessive reactive oxygen species (ROS), inhibit osteoblast differentiation and promote osteoclast activation, driving bone metabolism from a homeostatic toward a pathological state. In recent years, the roles of protein post-translational modifications (PTMs) in the regulation of oxidative stress have attracted increasing attention. By modulating the activity and stability of oxidative stress-related proteins, PTMs constitute an upstream regulatory tier of oxidative stress at multiple levels, including ROS generation, antioxidant defense, and mitochondrial function, and subsequently influence the differentiation and function of osteoblasts and osteoclasts. This review systematically summarizes the mechanisms by which major PTMs, including O-GlcNAcylation, acetylation, ubiquitination, phosphorylation, methylation, SUMOylation, and succinylation, participate in bone metabolism through the regulation of oxidative stress, and outlines recent advances in small-molecule compounds targeting PTM-mediated regulation of oxidative stress for bone protection. This review concludes that although different PTMs act on distinct targets, they largely converge on a common pathway whereby altered protein modification status regulates cellular redox levels and modulates bone metabolic phenotypes. It also emphasizes that elucidating the molecular mechanisms of bone metabolic abnormalities from the perspective of PTM-mediated regulation of oxidative stress may provide novel insights into the mechanistic understanding and targeted intervention of bone metabolic diseases.
Related
- Direct regulation of a tRNA modification enzyme by ppGpp links stress signaling to translational control and biofilm development
- METTL3-mediated m⁶A modification targets the regulation of PCBP1 expression, thereby modulating GPX4 levels and intracellular Fe²⁺ homeostasis to influence ferroptosis and contribute to juvenile sepsis-associated brain injury.
- Exercise-Mediated Regulation of Pyroptosis in Diabetes and Its Complications: Molecular Mechanisms and Translational Perspectives
- P2Y receptor-mediated regulation of lipolysis, lipid droplet dynamics, and energy metabolism in podocytes
- Dual regulation of the receptor-like kinase BIR1 involves site-directed transcript cleavage and 5’-leader-mediated translational control
BibTeX
@article{zou2026posttranslational,
title = {{The Post-Translational Modification-Mediated Regulation of Oxidative Stress in Bone Metabolism}},
author = {Yaoting Zou and Yaoqiang Weng and Yuxin Yan and Shengxuan Wu and Xuleqin Ye and Hui Yan and Dezun Ma},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = nov,
doi = {10.3390/ijms272210246},
url = {https://www.mdpi.com/1422-0067/27/22/10246},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The Post-Translational Modification-Mediated Regulation of Oxidative Stress in Bone Metabolism
AU - Yaoting Zou
AU - Yaoqiang Weng
AU - Yuxin Yan
AU - Shengxuan Wu
AU - Xuleqin Ye
AU - Hui Yan
AU - Dezun Ma
PY - 2026
DA - 2026/11/15
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms272210246
UR - https://www.mdpi.com/1422-0067/27/22/10246
AB - Bone remodeling depends on the dynamic equilibrium between osteogenic and osteoclastic processes, and its imbalance is considered one of the important foundations for the occurrence of bone metabolic diseases such as osteoporosis, osteoarthritis, and inflammation-related bone destruction, and may contribute to promoting their development. Oxidative stress can disrupt intracellular redox homeostasis through excessive reactive oxygen species (ROS), inhibit osteoblast differentiation and promote osteoclast activation, driving bone metabolism from a homeostatic toward a pathological state. In recent years, the roles of protein post-translational modifications (PTMs) in the regulation of oxidative stress have attracted increasing attention. By modulating the activity and stability of oxidative stress-related proteins, PTMs constitute an upstream regulatory tier of oxidative stress at multiple levels, including ROS generation, antioxidant defense, and mitochondrial function, and subsequently influence the differentiation and function of osteoblasts and osteoclasts. This review systematically summarizes the mechanisms by which major PTMs, including O-GlcNAcylation, acetylation, ubiquitination, phosphorylation, methylation, SUMOylation, and succinylation, participate in bone metabolism through the regulation of oxidative stress, and outlines recent advances in small-molecule compounds targeting PTM-mediated regulation of oxidative stress for bone protection. This review concludes that although different PTMs act on distinct targets, they largely converge on a common pathway whereby altered protein modification status regulates cellular redox levels and modulates bone metabolic phenotypes. It also emphasizes that elucidating the molecular mechanisms of bone metabolic abnormalities from the perspective of PTM-mediated regulation of oxidative stress may provide novel insights into the mechanistic understanding and targeted intervention of bone metabolic diseases.
SN - 1422-0067
ER -